HRT Financial’s InspireMD NSPR Stock Holding History

HRT Financial’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,089	Closed	-$17K	–	4425
2025 Q4	$17K	Buy	+10,089	New	+$21K	﹤0.01%	3000

Other funds holding NSPR

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

HRT Financial's NSPR Position: Q1 2026 in Review

HRT Financial sold out of InspireMD (NSPR) in Q1 2026, closing a stake of 10,089 shares — an estimated $17K sold.

HRT Financial first reported a position in NSPR in Q4 2025 and held it in 1 quarter. The position peaked at $17K in Q4 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

HRT Financial reported no remaining InspireMD position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 10,089 InspireMD shares in Q1 2026, an estimated $17K.
HRT Financial first reported a position in InspireMD in Q4 2025 and held it in 1 quarter.
HRT Financial's InspireMD position peaked at $17K in Q4 2025.
35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.